PT  - JOURNAL ARTICLE
AU  - Sarah Al Youha
AU  - Suhail A. Doi
AU  - Mohammad H. Jamal
AU  - Sulaiman Almazeedi
AU  - Mohannad Al Haddad
AU  - Mohammad AlSeaidan
AU  - Ali Al-Muhaini
AU  - Fahad Al-Ghimlas
AU  - Salman Al-Sabah
TI  - Validation of the Kuwait Progression Indicator Score for predicting progression of severity in COVID19
AID  - 10.1101/2020.05.21.20108639
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.21.20108639
4099  - http://medrxiv.org/content/early/2020/05/23/2020.05.21.20108639.short
4100  - http://medrxiv.org/content/early/2020/05/23/2020.05.21.20108639.full
AB  - Introduction Identifying patients with COVID-19, at risk of having a severe clinical course during their hospitalization is important for appropriate allocation of clinical resources. We recently described the ‘Kuwait Progression Indicator’ based on laboratory findings, in an initial training cohort derived from the first series of 1096 consecutive patients admitted to Jaber Al-Ahmad Al-Sabah Hospital in Kuwait. The aim of this study was to validate the KPI scoring system in an independent cohort of patients with COVID-19.Methodology Data was collected prospectively for consecutive patients admitted to Jaber Al-Ahmad Al-Sabah Hospital in Kuwait between 24th February – 28th April 2020. Patients were grouped according to the severity of their clinical course as their main outcome, based on clinical and radiological parameters, with ICU admission and death as secondary outcomes. Model discrimination was assessed through the area under the receiver operating characteristic curve (AUC) while model calibration was assessed through a calibration plot and measures of slope and calibration in the large (CITL).Results Of 752 patients not used in model development previously, 414 met the criteria for inclusion in this validation study. The baseline characteristics for these 752 patients were similar to the patients that were included in our validation cohort. The area under the curve was equal to 0.904 (95% CI, 0.867-0.942), indicating good model discrimination. The calibration plot and CITL confirmed reasonably good model calibration. Sensitivity and specificity were above 90% for the low and high risk levels respectively.Conclusions We were able to validate our previously described laboratory based prognostic scoring system for COVID-19 patients, to predict which patients progressed to a severe clinical course.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Kuwait Foundation for the Advancement of ScienceAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the Ministry of Health Kuwait for this studyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data included in the manuscript is available on request